Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms of resistance to macrophage checkpoint inhibitors in B-cell non-Hodgkin lymphoma for the British Journal of Haematology.

British journal of haematology·2026
Same author

Targeting eIF4A-dependent translation in genetically complex sarcoma.

JCI insight·2026
Same author

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma.

The Journal of experimental medicine·2024
Same author

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.

bioRxiv : the preprint server for biology·2024
Same author

Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma.

Blood cancer journal·2024

Related Experiment Video

Updated: Jul 9, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Dissecting eIF4E action in tumorigenesis.

Hans-Guido Wendel1, Ricardo L A Silva, Abba Malina

  • 1Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. wendelh@mskcc.org

Genes & Development
|December 7, 2007
PubMed
Summary
This summary is machine-generated.

The translation initiation factor eIF4E drives cancer by activating translation and suppressing apoptosis. Targeting this oncogenic activity, particularly through its kinase MNK1, offers a potential therapeutic strategy for cancer treatment.

More Related Videos

Xenopus laevis as a Model to Identify Translation Impairment
10:24

Xenopus laevis as a Model to Identify Translation Impairment

Published on: September 27, 2015

Identification of Protein Interacting Partners Using Tandem Affinity Purification
10:02

Identification of Protein Interacting Partners Using Tandem Affinity Purification

Published on: February 25, 2012

Related Experiment Videos

Last Updated: Jul 9, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Xenopus laevis as a Model to Identify Translation Impairment
10:24

Xenopus laevis as a Model to Identify Translation Impairment

Published on: September 27, 2015

Identification of Protein Interacting Partners Using Tandem Affinity Purification
10:02

Identification of Protein Interacting Partners Using Tandem Affinity Purification

Published on: February 25, 2012

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Genetically engineered mouse models are crucial for cancer gene research and therapeutic target validation.
  • The translation initiation factor eIF4E has been identified as a potent oncogene in vivo.

Purpose of the Study:

  • To investigate the correlation between eIF4E's oncogenic activity and its translational control functions.
  • To explore the role of MNK1, a kinase for eIF4E, in tumorigenesis.
  • To identify therapeutic targets within the eIF4E-mediated translational control pathway.

Main Methods:

  • Utilized a previously established mouse lymphoma model.
  • Assessed the phosphorylation of eIF4E on Ser 209 and its correlation with oncogenic activity.
  • Investigated the effects of constitutively active and dominant-negative MNK1 mutants on tumor cell proliferation.
  • Examined the role of the anti-apoptotic protein Mcl-1 as a downstream target.

Main Results:

  • The oncogenic activity of eIF4E in vivo is linked to its translation-activating function and Ser 209 phosphorylation.
  • Activated MNK1 promotes tumorigenesis similarly to eIF4E.
  • A dominant-negative MNK1 mutant suppressed tumor cell proliferation.
  • Phosphorylated eIF4E and MNK1 contribute to tumor formation by suppressing apoptosis, partly through regulating Mcl-1.

Conclusions:

  • eIF4E contributes to tumorigenesis by enhancing translation and suppressing apoptosis.
  • MNK1 plays a significant role in eIF4E-driven tumorigenesis.
  • Translational control mediated by eIF4E and MNK1 represents a potential therapeutic intervention point for cancer.